TP53 and Cerebral ischemia: Inhibition of HIF-1α has been reported to reduce BBB damage and improve recovery from cerebral ischemia in rats [28, 55], possibly by reducing levels of VEGF and attenuating the expression of cleaved caspase-3 and p53, which are key molecules in the apoptosis pathway [56].